321 related articles for article (PubMed ID: 12196343)
1. Accumulation of foam cells in liver X receptor-deficient mice.
Schuster GU; Parini P; Wang L; Alberti S; Steffensen KR; Hansson GK; Angelin B; Gustafsson JA
Circulation; 2002 Aug; 106(9):1147-53. PubMed ID: 12196343
[TBL] [Abstract][Full Text] [Related]
2. Different roles of liver X receptor alpha and beta in lipid metabolism: effects of an alpha-selective and a dual agonist in mice deficient in each subtype.
Lund EG; Peterson LB; Adams AD; Lam MH; Burton CA; Chin J; Guo Q; Huang S; Latham M; Lopez JC; Menke JG; Milot DP; Mitnaul LJ; Rex-Rabe SE; Rosa RL; Tian JY; Wright SD; Sparrow CP
Biochem Pharmacol; 2006 Feb; 71(4):453-63. PubMed ID: 16325781
[TBL] [Abstract][Full Text] [Related]
3. Liver X receptor (LXR)-beta regulation in LXRalpha-deficient mice: implications for therapeutic targeting.
Quinet EM; Savio DA; Halpern AR; Chen L; Schuster GU; Gustafsson JA; Basso MD; Nambi P
Mol Pharmacol; 2006 Oct; 70(4):1340-9. PubMed ID: 16825483
[TBL] [Abstract][Full Text] [Related]
4. Promoter-specific roles for liver X receptor/corepressor complexes in the regulation of ABCA1 and SREBP1 gene expression.
Wagner BL; Valledor AF; Shao G; Daige CL; Bischoff ED; Petrowski M; Jepsen K; Baek SH; Heyman RA; Rosenfeld MG; Schulman IG; Glass CK
Mol Cell Biol; 2003 Aug; 23(16):5780-9. PubMed ID: 12897148
[TBL] [Abstract][Full Text] [Related]
5. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta.
Repa JJ; Liang G; Ou J; Bashmakov Y; Lobaccaro JM; Shimomura I; Shan B; Brown MS; Goldstein JL; Mangelsdorf DJ
Genes Dev; 2000 Nov; 14(22):2819-30. PubMed ID: 11090130
[TBL] [Abstract][Full Text] [Related]
6. Gene-selective modulation by a synthetic oxysterol ligand of the liver X receptor.
Quinet EM; Savio DA; Halpern AR; Chen L; Miller CP; Nambi P
J Lipid Res; 2004 Oct; 45(10):1929-42. PubMed ID: 15292374
[TBL] [Abstract][Full Text] [Related]
7. Retinoic acid receptor-mediated induction of ABCA1 in macrophages.
Costet P; Lalanne F; Gerbod-Giannone MC; Molina JR; Fu X; Lund EG; Gudas LJ; Tall AR
Mol Cell Biol; 2003 Nov; 23(21):7756-66. PubMed ID: 14560020
[TBL] [Abstract][Full Text] [Related]
8. Induction of human liver X receptor alpha gene expression via an autoregulatory loop mechanism.
Li Y; Bolten C; Bhat BG; Woodring-Dietz J; Li S; Prayaga SK; Xia C; Lala DS
Mol Endocrinol; 2002 Mar; 16(3):506-14. PubMed ID: 11875109
[TBL] [Abstract][Full Text] [Related]
9. 27-hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded cells.
Fu X; Menke JG; Chen Y; Zhou G; MacNaul KL; Wright SD; Sparrow CP; Lund EG
J Biol Chem; 2001 Oct; 276(42):38378-87. PubMed ID: 11504730
[TBL] [Abstract][Full Text] [Related]
10. LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes.
Laffitte BA; Repa JJ; Joseph SB; Wilpitz DC; Kast HR; Mangelsdorf DJ; Tontonoz P
Proc Natl Acad Sci U S A; 2001 Jan; 98(2):507-12. PubMed ID: 11149950
[TBL] [Abstract][Full Text] [Related]
11. Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma.
Li AC; Binder CJ; Gutierrez A; Brown KK; Plotkin CR; Pattison JW; Valledor AF; Davis RA; Willson TM; Witztum JL; Palinski W; Glass CK
J Clin Invest; 2004 Dec; 114(11):1564-76. PubMed ID: 15578089
[TBL] [Abstract][Full Text] [Related]
12. Oxidized LDL upregulated ATP binding cassette transporter-1 in THP-1 macrophages.
Tang CK; Yi GH; Yang JH; Liu LS; Wang Z; Ruan CG; Yang YZ
Acta Pharmacol Sin; 2004 May; 25(5):581-6. PubMed ID: 15132822
[TBL] [Abstract][Full Text] [Related]
13. Diet-dependent cardiovascular lipid metabolism controlled by hepatic LXRalpha.
Lehrke M; Lebherz C; Millington SC; Guan HP; Millar J; Rader DJ; Wilson JM; Lazar MA
Cell Metab; 2005 May; 1(5):297-308. PubMed ID: 16054077
[TBL] [Abstract][Full Text] [Related]
14. Effect of macrophage overexpression of murine liver X receptor-alpha (LXR-alpha) on atherosclerosis in LDL-receptor deficient mice.
Teupser D; Kretzschmar D; Tennert C; Burkhardt R; Wilfert W; Fengler D; Naumann R; Sippel AE; Thiery J
Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):2009-15. PubMed ID: 18787185
[TBL] [Abstract][Full Text] [Related]
15. Synthetic LXR agonist attenuates plaque formation in apoE-/- mice without inducing liver steatosis and hypertriglyceridemia.
Kratzer A; Buchebner M; Pfeifer T; Becker TM; Uray G; Miyazaki M; Miyazaki-Anzai S; Ebner B; Chandak PG; Kadam RS; Calayir E; Rathke N; Ahammer H; Radovic B; Trauner M; Hoefler G; Kompella UB; Fauler G; Levi M; Levak-Frank S; Kostner GM; Kratky D
J Lipid Res; 2009 Feb; 50(2):312-26. PubMed ID: 18812595
[TBL] [Abstract][Full Text] [Related]
16. Tissue-specific autoregulation of the LXRalpha gene facilitates induction of apoE in mouse adipose tissue.
Ulven SM; Dalen KT; Gustafsson JA; Nebb HI
J Lipid Res; 2004 Nov; 45(11):2052-62. PubMed ID: 15292368
[TBL] [Abstract][Full Text] [Related]
17. Macrophage cholesterol transport: a critical player in foam cell formation.
Vainio S; Ikonen E
Ann Med; 2003; 35(3):146-55. PubMed ID: 12822736
[TBL] [Abstract][Full Text] [Related]
18. Adiponectin increases macrophages cholesterol efflux and suppresses foam cell formation in patients with type 2 diabetes mellitus.
Wang M; Wang D; Zhang Y; Wang X; Liu Y; Xia M
Atherosclerosis; 2013 Jul; 229(1):62-70. PubMed ID: 23466101
[TBL] [Abstract][Full Text] [Related]
19. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers.
Repa JJ; Turley SD; Lobaccaro JA; Medina J; Li L; Lustig K; Shan B; Heyman RA; Dietschy JM; Mangelsdorf DJ
Science; 2000 Sep; 289(5484):1524-9. PubMed ID: 10968783
[TBL] [Abstract][Full Text] [Related]
20. Antiatherosclerotic effect of farnesoid X receptor.
Mencarelli A; Renga B; Distrutti E; Fiorucci S
Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H272-81. PubMed ID: 19028791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]